LBP-1C Inhibitors
LBP-1C inhibitors are a class of chemical compounds that specifically target and inhibit LBP-1C, a protein involved in transcriptional regulation. LBP-1C, or Lipid-Binding Protein 1C, is a transcription factor that plays a crucial role in controlling the expression of various genes, particularly those associated with lipid metabolism and cellular growth processes. The protein binds to specific DNA sequences within promoter regions of target genes, influencing their transcriptional activity. Inhibitors of LBP-1C function by blocking its ability to bind to DNA or by disrupting its interactions with co-factors necessary for effective gene regulation. This inhibition can alter the transcriptional landscape within the cell, impacting the expression levels of genes regulated by LBP-1C.
The inhibition of LBP-1C provides researchers with an important tool to study gene expression patterns and the molecular mechanisms by which LBP-1C controls lipid-related pathways and other cellular functions. By blocking LBP-1C, these inhibitors allow scientists to observe changes in cellular metabolism, lipid homeostasis, and gene regulatory networks. Since LBP-1C interacts with other transcription factors and regulatory proteins, inhibiting its activity also helps uncover the broader role of transcriptional complexes and their impact on cellular physiology. This inhibition sheds light on how transcriptional regulators like LBP-1C coordinate with metabolic pathways, providing a deeper understanding of gene regulation dynamics. These insights are crucial for further exploring the complex interactions between metabolism, gene expression, and cellular growth.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone deacetylase inhibitor, can affect chromatin structure and thereby influence TFCP2-mediated transcription. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitor, potentially affecting gene expression and thus influencing TFCP2. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Histone deacetylase inhibitor, could affect TFCP2 function through epigenetic regulation. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Hypomethylating agent, could influence gene expression including that of TFCP2. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
Inhibits BET bromodomains, potentially influencing transcription factors and mediator complex including TFCP2. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Rho kinase inhibitor, could indirectly influence TFCP2-related cellular processes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor, could impact cell signaling and growth pathways, potentially affecting TFCP2. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor, could indirectly affect TFCP2 function through signaling pathway modulation. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Broad-spectrum kinase inhibitor, may affect multiple pathways including those involving TFCP2. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
CDK4/6 inhibitor, potentially influences cell cycle regulation mechanisms involving TFCP2. | ||||||